Notably 19 of the 99 unique variants in the 3.6 N ploidy were fixed and targeted non-coding regions of genes with well characterized roles in breast cancer and a variety of tumors including ATR, CHD3, RPS6KA2, and IRF3 in PS13-1750 (Fig. 3C). This evidence concerns the gene RPS6KA2 and breast cancer.